Back to LCTX
Farther Finance Advisors, LLC → LCTX
Farther Finance Advisors, LLC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
10
Latest value
$200K
Q3 2026
Peak value
$391K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $142 |
| Q3 2025 | $3K |
| Q4 2025 | $149 |
| Q4 2025 | $14K |
| Q1 2026 | $865 |
| Q1 2026 | $391K |
| Q2 2026 | $713 |
| Q2 2026 | $360K |
| Q3 2026 | $1K |
| Q3 2026 | $200K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $200K | 5.9K | — | — |
| Q3 2026 | $1K | 1.1K | — | — |
| Q2 2026 | $360K | 8.3K | — | — |
| Q2 2026 | $713 | 544 | — | — |
| Q1 2026 | $391K | 11.9K | — | — |
| Q1 2026 | $865 | 544 | — | — |
| Q4 2025 | $14K | 392 | — | — |
| Q4 2025 | $149 | 89 | — | — |
| Q3 2025 | $3K | 76 | — | — |
| Q3 2025 | $142 | 84 | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M